In fact, TRIM44 is associated with tumor progression in over 10 types of cancer, including thyroid cancer [50,51], esophageal cancer [52,53,54], gastric cancer [55,56,57], lung cancer [58,59,60,61,62], hepatocellular carcinoma [63], colorectal cancer [64,65,66], ovarian cancer [67,68,69], cervical cancer [70], breast cancer [71], prostate cancer [72,73], and testicular cancer [74]. This evidence concerns the gene TRIM44 and prostate carcinoma.